Neveen Said to Urinary Bladder Neoplasms
This is a "connection" page, showing publications Neveen Said has written about Urinary Bladder Neoplasms.
Connection Strength
1.991
-
Said N. Roles of SPARC in urothelial carcinogenesis, progression and metastasis. Oncotarget. 2016 Oct 11; 7(41):67574-67585.
Score: 0.484
-
Said N, Frierson HF, Sanchez-Carbayo M, Brekken RA, Theodorescu D. Loss of SPARC in bladder cancer enhances carcinogenesis and progression. J Clin Invest. 2013 Feb; 123(2):751-66.
Score: 0.373
-
Said N, Sanchez-Carbayo M, Smith SC, Theodorescu D. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. J Clin Invest. 2012 Apr; 122(4):1503-18.
Score: 0.352
-
Said N, Smith S, Sanchez-Carbayo M, Theodorescu D. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J Clin Invest. 2011 Jan; 121(1):132-47.
Score: 0.323
-
Said N, Theodorescu D. Pathways of metastasis suppression in bladder cancer. Cancer Metastasis Rev. 2009 Dec; 28(3-4):327-33.
Score: 0.301
-
Huttanus HM, Vu T, Guruli G, Tracey A, Carswell W, Said N, Du P, Parkinson BG, Orlando G, Robertson JL, Senger RS. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer. PLoS One. 2020; 15(8):e0237070.
Score: 0.158